The U.S. National Toxicology Program evaluation of transgenic mice as predictive models for identifying carcinogens

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 1, 1998, Pages 81-84

  Eastin, William C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Carcinogen; Model; NTP; P53(+ ); Tg.AC; Transgenic

Indexed keywords

CARCINOGEN; PROTEIN P53;

ANIMAL MODEL; CARCINOGEN TESTING; DOSIMETRY; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; RISK; SHORT SURVEY; TARGET ORGAN; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE; UNITED STATES;

EID: 0031977884     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106s181     Document Type: Short Survey

References (15)

1. Doll R. Nature and nurture: possibilities for cancer control. Carcinogenesis 17:177-184 (1996).
2. U.S. NTP. Specification for the Conduct of Studies to Evaluate the Toxic and Carcinogenic Potential of Chemical, Biological and Physical Agents in Laboratory Animals for the National Toxicology Program (NTP), Research Triangle Park, NC. Research Triangle Park, NC:U.S. National Toxicology Program, 1992.
3. OECD. OECD guidelines for testing of chemicals. Paris:Organisation for Economic Co-operation and Development, 1981.
4. U.S. Environmental Protection Agency. Health effects test guidelines. EPA 560/6-82-001. Washingtont:U.S. Environmental Protection Agency, 1982.
5. U.S. Food and Drug Administration. Toxicological principles for the safety assessment of direct food additives and color additives used in food (draft: Redbook II). Fed Reg 58(58): 16536-16537 (1993).
6. Walker J. Toxic Substances Control Act (TSCA) Interagency Testing Committee: Data developed under section 4 of TSCA. In: Fundamentals of Aquatic Toxicology (Rand GM, ed). Washington:Taylor & Francis, 1995.
7. U.S. NTP. National Toxicology Program Annual Plan for Fiscal Year 1996. Research Triangle Park, NC:U.S. National Toxicology Program, 1996.
8. U.S. Congress. National Institutes of Health Revitalization Act. Public Law 103-43, 42 U.S.C. 1301. Washington:U.S. Government Printing Office, 1993.
9. Lucier GW. Mechanism-based toxicology in cancer risk assessment: implications for research, regulation and legislation. Environ Health Perspect 104:84-88 (1996).
10. Tennant RW, French JE, Spalding JW. Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ Health Perspect 103:942-950 (1995).
11. Tennant RW, Spalding J, French JE. Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens. Mutat Res 365:119-127 (1996).
12. Leder A, Kuo A, Cardiff RD, Sinn E, Leder P. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc Natl Acad Sci USA 87:9178-9182 (1990).
13. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CAJ, Butel JS, Bradley A. Mice deficient for p53 are developmentally normal but susceptible to sponetaneous tumors. Nature 356:215-221 (1992).
14. Tennant RW, Zeiger E. Genetic toxicology: current status of methods of carcinogen identification. Environ Health Perspect 100:307-315 (1993).
15. U.S. Food and Drug Administration. International Conference on Harmonisation; draft guideline on testing for carcinogenicity of pharmaceutical; notice. Fed Reg 61(163):43298-43300 (1996).